Celldex Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
78.5M
on 2026-06-30, from 65.9M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
12.2 quarters
$717.6M on 2026-06-30 ÷ $58.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-04-01 | Public offering | 10,345,000 | $29.00 | $300.0M | 424B5 ↗ |